Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 36

1.

Prevalence of vitamin D deficiency in women from southern Brazil and association with vitamin D-binding protein levels and GC-DBP gene polymorphisms.

Santos BR, Costa NC, Silva TR, Oppermann K, Magalhães JA, Casanova G, Spritzer PM.

PLoS One. 2019 Dec 12;14(12):e0226215. doi: 10.1371/journal.pone.0226215. eCollection 2019.

2.

Prevalence and characteristics of polycystic ovary syndrome in Brazilian women: protocol for a nation-wide case-control study.

Spritzer PM, Marchesan LB, Santos BR, Cureau FV, Oppermann K, Reis RMD, Ferriani RA, Weiss R, Meirelles R, Candido AL, Reis FM; Brazilian PCOS Network.

BMJ Open. 2019 Oct 22;9(10):e029191. doi: 10.1136/bmjopen-2019-029191.

3.

Conversion and reversion of anti-John Cunningham virus antibody serostatus: A prospective study.

Auer M, Hegen H, Sellner J, Oppermann K, Bsteh G, Di Pauli F, Berger T, Deisenhammer F.

Brain Behav. 2019 Jul;9(7):e01332. doi: 10.1002/brb3.1332. Epub 2019 Jun 6.

4.

Risk factors associated with coronary artery calcification in midlife women: a population-based study.

Oppermann K, Colpani V, Spritzer PM.

Gynecol Endocrinol. 2019 Apr 22:1-5. doi: 10.1080/09513590.2019.1604656. [Epub ahead of print]

PMID:
31006278
5.

Verrucous hemangioma and histopathological differential diagnosis with angiokeratoma circumscriptum neviforme.

Oppermann K, Boff AL, Bonamigo RR.

An Bras Dermatol. 2018 Sep-Oct;93(5):712-715. doi: 10.1590/abd1806-4841.20187259.

6.

PLECT or PPLECT? Granulomatous pyoderma gangrenosum in the differential diagnosis of the verrucous syndrome.

Oppermann K, Cocco AR, Heck R, Bonamigo RR.

An Bras Dermatol. 2018 Jul-Aug;93(4):605-607. doi: 10.1590/abd1806-4841.20187329.

7.

From natalizumab to fingolimod in eight weeks - Immunological, clinical, and radiological data in quest of the optimal switch.

Harrer A, Pilz G, Oppermann K, Sageder M, Afazel S, Haschke-Becher E, Rispens T, de Vries A, McCoy M, Stevanovic V, Hitzl W, Trinka E, Kraus J, Sellner J, Wipfler P.

Clin Immunol. 2017 Mar;176:87-93. doi: 10.1016/j.clim.2017.01.001. Epub 2017 Jan 17.

PMID:
28108364
8.

The Passo Fundo Cohort Study: design of a population-based observational study of women in premenopause, menopausal transition, and postmenopause.

Oppermann K, Colpani V, Fuchs SC, Spritzer PM.

Womens Midlife Health. 2015 Dec 18;1:12. doi: 10.1186/s40695-015-0013-8. eCollection 2015.

9.

Adaptive Immune Responses in a Multiple Sclerosis Patient with Acute Varicella-Zoster Virus Reactivation during Treatment with Fingolimod.

Harrer A, Wipfler P, Pilz G, Oppermann K, Haschke-Becher E, Afazel S, Kraus J, Trinka E, Sellner J.

Int J Mol Sci. 2015 Sep 10;16(9):21832-45. doi: 10.3390/ijms160921832.

10.

High interindividual variability in the CD4/CD8 T cell ratio and natalizumab concentration levels in the cerebrospinal fluid of patients with multiple sclerosis.

Harrer A, Pilz G, Wipfler P, Oppermann K, Sellner J, Hitzl W, Haschke-Becher E, Afazel S, Rispens T, van der Kleij D, Trinka E, Kraus J.

Clin Exp Immunol. 2015 Jun;180(3):383-92. doi: 10.1111/cei.12590. Epub 2015 Apr 27.

11.

Physical activity in climacteric women: comparison between self-reporting and pedometer.

Colpani V, Spritzer PM, Lodi AP, Dorigo GG, Miranda IA, Hahn LB, Palludo LP, Pietroski RL, Oppermann K.

Rev Saude Publica. 2014 Apr;48(2):258-65. English, Portuguese.

12.

Causes of death and associated risk factors among climacteric women from Southern Brazil: a population based-study.

Colpani V, Oppermann K, Spritzer PM.

BMC Public Health. 2014 Feb 21;14:194. doi: 10.1186/1471-2458-14-194.

13.

Tumefactive MS lesions under fingolimod: a case report and literature review.

Pilz G, Harrer A, Wipfler P, Oppermann K, Sellner J, Fazekas F, Trinka E, Kraus J.

Neurology. 2013 Nov 5;81(19):1654-8. doi: 10.1212/01.wnl.0000435293.34351.11. Epub 2013 Oct 4. Review. Erratum in: Neurology. 2014 Apr 29;82(17):1569.

PMID:
24097813
14.

Natalizumab saturation: biomarker for individual treatment holiday after natalizumab withdrawal?

Wipfler P, Harrer A, Pilz G, Oppermann K, Afazel S, Haschke-Becher E, Sellner J, Trinka E, Kraus J.

Acta Neurol Scand. 2014 Mar;129(3):e12-5. doi: 10.1111/ane.12182. Epub 2013 Aug 30.

PMID:
24032536
15.

Association between habitual physical activity and lower cardiovascular risk in premenopausal, perimenopausal, and postmenopausal women: a population-based study.

Colpani V, Oppermann K, Spritzer PM.

Menopause. 2013 May;20(5):525-31. doi: 10.1097/GME.0b013e318271b388.

PMID:
23615643
16.

Glatiramer acetate attenuates the pro-migratory profile of adhesion molecules on various immune cell subsets in multiple sclerosis.

Sellner J, Koczi W, Harrer A, Oppermann K, Obregon-Castrillo E, Pilz G, Wipfler P, Afazel S, Haschke-Becher E, Trinka E, Kraus J.

Clin Exp Immunol. 2013 Sep;173(3):381-9. doi: 10.1111/cei.12125.

17.

A case of late-onset oligomeganephronia.

Alves RJ, Oppermann K, Schein LE, Pêgas KL.

J Bras Nefrol. 2012 Oct-Dec;34(4):392-4.

18.

Weight gain and abdominal obesity at menopause.

Spritzer PM, Oppermann K.

Climacteric. 2013 Apr;16(2):292. doi: 10.3109/13697137.2012.753874. Epub 2012 Dec 31. No abstract available.

PMID:
23276232
19.

Lymphocyte subsets show different response patterns to in vivo bound natalizumab--a flow cytometric study on patients with multiple sclerosis.

Harrer A, Pilz G, Einhaeupl M, Oppermann K, Hitzl W, Wipfler P, Sellner J, Golaszewski S, Afazel S, Haschke-Becher E, Trinka E, Kraus J.

PLoS One. 2012;7(2):e31784. doi: 10.1371/journal.pone.0031784. Epub 2012 Feb 20.

20.

Isolated leptomeningeal infiltration of a primary CNS B-cell lymphoma diagnosed by flow cytometry and confirmed by necropsy.

Broussalis E, Hutterer M, Oppermann K, Wipfler P, Pilz G, Harrer A, Haschke-Becher E, Golaszewski S, Schönauer U, Weis S, Killer-Oberpfalzer M, Mc Coy M, Trinka E, Kraus J.

Acta Neurol Scand. 2012 Sep;126(3):e11-6. doi: 10.1111/j.1600-0404.2011.01630.x. Epub 2011 Dec 26.

PMID:
22211863
21.

Physical, psychological, and menopause-related symptoms and minor psychiatric disorders in a community-based sample of Brazilian premenopausal, perimenopausal, and postmenopausal women.

Oppermann K, Fuchs SC, Donato G, Bastos CA, Spritzer PM.

Menopause. 2012 Mar;19(3):355-60. doi: 10.1097/gme.0b013e31822ba026.

PMID:
21971211
22.

Molecular evidence of transient therapeutic effectiveness of natalizumab despite high-titre neutralizing antibodies.

Pilz G, Harrer A, Oppermann K, Wipfler P, Golaszewski S, Afazel S, Haschke-Becher E, Trinka E, Kraus J.

Mult Scler. 2012 Apr;18(4):506-9. doi: 10.1177/1352458511423650. Epub 2011 Sep 30.

PMID:
21965415
23.

Natalizumab therapy decreases surface expression of both VLA-heterodimer subunits on peripheral blood mononuclear cells.

Harrer A, Wipfler P, Einhaeupl M, Pilz G, Oppermann K, Hitzl W, Afazel S, Haschke-Becher E, Strasser P, Trinka E, Kraus J.

J Neuroimmunol. 2011 May;234(1-2):148-54. doi: 10.1016/j.jneuroim.2011.03.001. Epub 2011 Mar 29.

PMID:
21450349
24.

Recent developments in approved and oral multiple sclerosis treatment and an update on future treatment options.

Wipfler P, Harrer A, Pilz G, Oppermann K, Trinka E, Kraus J.

Drug Discov Today. 2011 Jan;16(1-2):8-21. doi: 10.1016/j.drudis.2010.10.011. Epub 2010 Nov 3. Review.

PMID:
21055477
25.

Adhesion molecules are promising candidates to establish surrogate markers for natalizumab treatment.

Wipfler P, Oppermann K, Pilz G, Afazel S, Haschke-Becher E, Harrer A, Huemer M, Kunz A, Golaszewski S, Staffen W, Ladurner G, Kraus J.

Mult Scler. 2011 Jan;17(1):16-23. doi: 10.1177/1352458510383075. Epub 2010 Oct 11.

PMID:
20937631
26.

Association between menopause status and central adiposity measured at different cutoffs of waist circumference and waist-to-hip ratio.

Donato GB, Fuchs SC, Oppermann K, Bastos C, Spritzer PM.

Menopause. 2006 Mar-Apr;13(2):280-5.

PMID:
16645541
27.

Determinants of ovarian volume in pre-, menopausal transition, and post-menopausal women: a population-based study.

Bastos CA, Oppermann K, Fuchs SC, Donato GB, Spritzer PM.

Maturitas. 2006 Mar 20;53(4):405-12. Epub 2005 Aug 18.

PMID:
16111843
28.

Ovarian volume in pre- and perimenopausal women: a population-based study.

Oppermann K, Fuchs SC, Spritzer PM.

Menopause. 2003 May-Jun;10(3):209-13.

PMID:
12792291
30.

[Expert assessment of initial surgical management after experimental chemical eye burn].

Becker J, Salla S, Werry C, Oppermann K, Meyer J.

Klin Monbl Augenheilkd. 1996 Aug-Sep;209(2-3):138-43. German.

PMID:
8992074
31.

Serum LH levels in the differential diagnosis of hirsute anovulatory women.

Oppermann K, Cho MM, Spritzer PM.

Braz J Med Biol Res. 1993 Aug;26(8):799-803.

PMID:
8298514
32.

Trends in medical school faculties.

POWERS L, WHITING JF, OPPERMANN KC.

J Med Educ. 1962 Oct;37:1065-91. No abstract available.

PMID:
13985841
33.

National goals for the construction of medical school facilities.

POWERS L, DARLEY W, OPPERMANN KC.

J Med Educ. 1960 Feb;35:108-19. No abstract available.

PMID:
14434580
34.

Hodgkin's disease: an analysis of frequency, distribution and mortality at the University of California Hospital 1914-1951.

SHIMKIN MB, OPPERMANN KC, BOSTICK WL, LOW-BEER BV.

Ann Intern Med. 1955 Jan;42(1):136-53. No abstract available.

PMID:
13229194
35.

Lymphosarcoma: an analysis of frequency, distribution and mortality at the University of California Hospital, 1913-1948.

SHIMKIN MB, OPPERMANN KC, LOWBEER BV, METTIER SR.

Ann Intern Med. 1954 Jun;40(6):1095-1107. No abstract available.

PMID:
13159081
36.

Lymphocytic leukemia; an analysis of frequency, distribution and mortality at the University of California Hospital, 1913-1947.

SHIMKIN MB, LUCIA EL, OPPERMANN KC, METTIER SR.

Ann Intern Med. 1953 Dec;39(6):1254-66. No abstract available.

PMID:
13105195

Supplemental Content

Loading ...
Support Center